Rubella IgG/IgM Rapid Test (WB/S/P)

The Rubella IgG/IgM Rapid Test is an antibody-based rapid test that helps detect immune response to rubella virus. IgG antibodies usually indicate previous exposure, vaccination response, or immunity, while IgM antibodies may suggest recent infection or recent immune response.

• Rubella, also called German measles, is usually mild in many people but can be clinically important during pregnancy.
• Rubella infection in early pregnancy may cause congenital rubella syndrome, making rubella immunity and infection assessment important in antenatal care.
• Rubella IgG testing may help assess whether a person has immunity from vaccination or previous infection.
• Rubella IgM testing requires careful interpretation and should be used with clinical evaluation and confirmatory testing when required.

The Rubella IgG/IgM Rapid Test by LARKSOIS Pharma may be used in professional ToRCH, antenatal, and infectious disease screening environments.

Applications

• ToRCH screening support
• Antenatal and pregnancy-related evaluation
• Hospitals and diagnostic laboratories
• Gynecology and fertility centers
• Infectious disease screening programs
• Public health and vaccination-status screening support
• Professional point-of-care testing
• Medical procurement agencies
• International diagnostic distribution

• The Rubella IgG/IgM Rapid Test works on lateral flow immunochromatographic assay technology.
• When the sample is applied to the device, it migrates across the test membrane by capillary action.
• If rubella-specific IgG or IgM antibodies are present, they bind with coated rubella antigens and generate visible test lines.
• The test generally includes an IgG line, IgM line, and control line for valid test performance.

The Rubella IgG/IgM Rapid Test uses rapid lateral flow immunochromatographic technology for qualitative detection and differentiation of rubella virus IgG and IgM antibodies in whole blood, serum, or plasma specimens.

Benefits

• Detects Rubella IgG antibodies
• Detects Rubella IgM antibodies
• Suitable for whole blood, serum, and plasma
• Rapid visual result
• Simple professional testing workflow
• No complex instrument required
• Useful for ToRCH-related screening support
• Suitable for hospitals, labs, and distributors

The Rubella IgG/IgM Rapid Test supports whole blood, serum, and plasma specimens. This flexibility makes the test practical for different clinical and laboratory screening workflows.

Guidance

• Use approved whole blood, serum, or plasma specimens only
• Collect specimens according to the product insert
• Use clean and suitable sample collection materials
• Avoid contaminated or improperly stored samples
• Apply the specimen correctly to the sample area
• Add buffer according to instructions
• Read results only within the recommended time window
• Handle all blood specimens as potentially infectious material

Note

Specimen collection, testing, timing, and storage should always follow the official LARKSOIS Pharma kit insert.

The Rubella IgG/IgM Rapid Test by LARKSOIS Pharma is designed for qualitative detection and differentiation of rubella virus IgG and IgM antibodies in whole blood, serum, or plasma specimens.

• Rubella IgG positive may suggest past exposure, vaccination response, or immunity.
• Rubella IgM positive may suggest recent infection or recent immune response and requires careful medical interpretation.
• Rubella testing is especially important in pregnancy-related evaluation and ToRCH screening support.
• Results should be interpreted with pregnancy status, symptoms, exposure history, vaccination history, and confirmatory laboratory testing when required.

The Rubella IgG/IgM Rapid Test is a professional screening aid and should not be used as the only basis for diagnosis or pregnancy-related clinical decisions. Rubella IgM results need careful interpretation and may require confirmatory testing.

Instructions

• For professional in-vitro diagnostic use only
• Use approved whole blood, serum, or plasma specimens only
• Improper specimen collection may affect results
• False positive or false negative results may occur
• IgM results should be interpreted carefully
• Clinical evaluation and confirmatory testing may be required
• Read results only within the recommended time
• Follow the official product insert carefully

Instructions

• Detects Rubella IgG antibodies
• Detects Rubella IgM antibodies
• Suitable for whole blood, serum, and plasma
• Rapid visual result
• Simple professional testing workflow
• No complex instrument required
• Useful for ToRCH-related screening support
• International-quality diagnostic product from LARKSOIS Pharma

Note

The Rubella IgG/IgM Rapid Test by LARKSOIS Pharma is designed for fast, practical, and accessible rubella antibody screening support.

Steps

• Bring the test device, specimen, and buffer to room temperature
• Open the sealed pouch only when ready to test
• Place the test device on a clean and flat surface
• Add whole blood, serum, or plasma to the sample area
• Add buffer according to the product insert
• Wait for the recommended reaction time
• Read the IgG, IgM, and control lines within the valid time window
• Do not interpret results after the recommended reading time
• Dispose of used materials according to laboratory safety procedures

Note

Testing should be performed by trained healthcare professionals according to the official LARKSOIS Pharma product insert.

Positive

Rubella IgG positive may suggest past exposure, vaccination response, or immunity. Rubella IgM positive may suggest recent infection or recent immune response and should be interpreted with clinical history and follow-up testing.

Negative

A negative result means Rubella IgG/IgM antibodies were not detected at the test’s detectable level.

Invalid

If the control line does not appear, the test is invalid and should be repeated with a new device.

Instructions

• Store the Rubella IgG/IgM Rapid Test according to the product label and insert
• Store in a cool and dry place
• Keep sealed until use
• Protect from heat, sunlight, and moisture
• Do not freeze unless specified
• Do not use expired kits
• Use immediately after opening the pouch
• Follow all instructions for use carefully

Instructions

• For professional in-vitro diagnostic use only
• Handle all blood specimens carefully
• Wear gloves and protective equipment during testing
• Do not reuse the test device
• Avoid specimen contamination
• Do not use damaged or expired kits
• Read results only within the recommended time
• Interpret results with clinical findings and patient history

LARKSOIS Pharma provides internationally suitable diagnostic products for hospitals, laboratories, clinics, healthcare distributors, and procurement agencies. The Rubella IgG/IgM Rapid Test (WB/S/P) is designed for fast, practical, and accessible rubella antibody screening support.

Advantages

• International infectious disease rapid test portfolio
• Reliable Rubella IgG/IgM antibody screening support
• Suitable for hospitals, clinics, and laboratories
• Distributor-friendly product support
• Professional healthcare quality standards
• Practical point-of-care diagnostic format
• Accessible ToRCH screening solution